Psychosis with Ordinary Doses of Propranolol
Authors: ELLIOT S. GERSHON
Journal: Annals of Internal Medicine (1979)

Brief Reports1 June 1979Psychosis with Ordinary Doses of PropranololELLIOT S. GERSHON, M.D., ROBERT E. GOLDSTEIN, M.D., ARTHUR J. MOSS, M.D., DANIEL P. van KAMMEN, M.D.ELLIOT S. GERSHON, M.D., ROBERT E. GOLDSTEIN, M.D., ARTHUR J. MOSS, M.D., DANIEL P. van KAMMEN, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-90-6-938 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptNeuropsychiatry symptoms occur not infrequently during treatment with propranolol. Although lassitude and depression are commonest, patients may also have vivid nightmares, hypnagogic hallucinations, or toxic psychosis, the latter generally after propranolol administration in high doses (more than 500 mg/d) (1, 2) or after treatment of patients with active major psychiatric illness (2) or hyperthyroidism (3). Recently, we observed paranoid psychosis resembling acute schizophrenia developing during administration of relatively low doses of propranolol (maximum, 160 mg/d) in a person with no pre-existing psychiatric illness.A healthy 21-year-old woman was admitted to the National Heart, Lung, and Blood Institute as a normal...References1. FRASERCARR HA: Propranolol psychosis. Br J Psychiatry 129:508-509, 1976 CrossrefMedlineGoogle Scholar2. YORKSTONZAKIMALIKMORRISONHAVARD NSMRC: Propranolol in the control of schizophrenic symptoms. Br Med J 4:633-635, 1974 CrossrefMedlineGoogle Scholar3. TOPLISSBOND DR: Acute brain syndrome after propranolol treatment (letter). Lancet 2:1133-1134, 1977 CrossrefMedlineGoogle Scholar4. WEINGARTNERVAN KAMMENDOCHERTYWHITE HDJR: The schizophrenic thought disorder, structure, storage and retrieval of information from memory. J Abnorm Psychol, in press Google Scholar5. KOEHLERGUTH KW: Schizophrenic-ähnliche Psychose nach Einnahme von Propranolol. Munch Med Wochenschr 119:443-444, 1977 Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: National Institute of Mental Health and National Heart, Blood, and Lung Institute National Institutes of Health Bethesda, Maryland PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByPropranolol and metoprolol: Two comparable drugs with very different post-mortem toxicological profilesDrug-Induced Tactile Hallucinations Beyond Recreational DrugsBeta-adrenoceptor antagonistsPSYCHOLOGICAL AND PSYCHIATRIC ADVERSE EFFECTS OF NON-PSYCHOACTIVE DRUGSDrugs Used to Treat Hypertension, Heart Failure, and Angina PectorisBeta-adrenoceptor antagonistsBeta-blocker supplementation of standard drug treatment for schizophreniaToxic psychosis: An unusual presentation of propranolol intoxicationDelirium Presenting With Symptoms of DepressionNeuropsychiatric Adverse Drug Reactions: Passive Reports to Health and Welfare Canada's Adverse Drug Reaction Database (1965-Present)Dissociation Precipitated by PropranololDelirium in hospitalized elderlyBETA-BLOCKERS AND LIPOPHILICITYCOPPER AND THE INFANTPsychosis with propranolol: still not recognized?Drug-Induced Psychiatric Disorders and their ManagementCNS-related (side-)effects of ?-Blockers with special reference to mechanisms of actionThe Intensive Care Unit Syndrome: Causes, Treatment, and PreventionPsychopharmacologic Issues in the Diagnosis and Treatment of Organic Mental DisordersPropranolol-Induced PsychosisPsychoses with Propranolol: A Case ReportSerum sickness-like syndrome associated with propranolol therapyPropranolol in Schizophrenia: A Double Blind, Placebo Controlled Trial of Propranolol as an Adjunct to Neuroleptic MedicationThe Use of Beta-Adrenergic Blocking Agents in Anxiety Disorders and SchizophreniaThe Use of Beta-Adrenergic Blocking Agents in Anxiety Disorders and SchizophreniaThe Risks and Course of Coronary Artery DiseasePropranolol in SchizophreniaBETA-BLOCKERS IN THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERSAdverse Psychiatric Reactions to Modern MedicationShortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjectsAntianginal and beta-adrenoceptor blocking drugsPsychosis with Oral Doses of PropranololIRVING H. GOMOLIN, M.D. 1 June 1979Volume 90, Issue 6Page: 938-939KeywordsBloodFatigueHallucinationsHeartHyperthyroidismLungsPatientsSchizophrenia Issue Published: 1 June 1979 PDF DownloadLoading ...